Tumors, the first study on a new type of drug conducted in Italy
Fifteen years ago someone began to bet on a new possible target to be used against cancer: microRNAs. Now that...
Fifteen years ago someone began to bet on a new possible target to be used against cancer: microRNAs. Now that...
Fatigue due to therapies, social isolation because many go on vacation, anxiety because treatments and checkups are interrupted. And then...
Plunging temperatures, high humidity and long days: a mix that especially knocks out the most fragile people including cancer patients...
Italian oncology meets the Peruvian one. It will happen next 10 and 11 August on the occasion of the international...
Dancing not only as fun and passion, but as an effective health ally. Dance is to all intents and purposes...
Acupuncture helps to soothe disorders related to female tumors (uterus, ovary, breast) and traditional treatments. We are not talking about...
A fleet of over 30 sailing boats challenged each other yesterday, July 2, on the Marche coast: from Senigallia to...
In Rome the third stage of the awareness campaign 'I know too' to communicate to all the progress made possible...
Leaving hospitals, doctors' surgeries and families affected by cancer to tell all those who will listen not only about living...
"Cancer is above all a pathology of the elderly, but perhaps it is the elderly patients whose needs and requirements...
After the campaign and the collection of over one hundred thousand signatures by the Aiom Foundation and after the bill...
They have a frightening name because it refers to something difficult to understand: they are tumors with TRK fusion that...
The drug-conjugated antibody trastuzumab deruxtecan, now used in a particular type of metastatic breast cancer, also appears to be effective...
A targeted therapy, the first, for brain tumors called low-grade gliomas, and capable of reaching exactly where it is needed,...
How many Italian patients could be treated with precision oncology? That is, with drugs that specifically target mutations that contribute...